Susan Wyllie

Susan Wyllie
Academic background
EducationUniversity of Edinburgh (PhD, BSc)
ThesisStructural and functional characterisation of the major outer membrane protein of Chlamydia Psittaci (1998)
Academic work
DisciplineBiochemist
InstitutionsUniversity of Dundee
University of North Carolina at Chapel Hill

Susan Wyllie is an British biochemist and academic. She is currently the professor of biochemical pharmacology at the University of Dundee, and she was awarded a Fellowship of the Royal Society of Edinburgh in 2026.

Early life and education

Wyllie grew up in Coldstream, Scotland.

In 1991, Wyllie enrolled at the University of Edinburgh and studied biochemistry. In 1995, she graduated with a Bachelor of Science. Under the supervision of David Longbottom and Richard Ashley, she continued research into Chlamydia at the Moredun Research Institute. Her thesis was titled Structural and functional characterisation of the major outer membrane protein of Chlamydia Psittaci. In 1998, Wyllie was conferred a Doctor of Philosophy.

Career

Upon graduation, Wyllie joined the University of North Carolina at Chapel Hill, as a postdoctoral researcher under Jane E. Raulston. She continued researching into Chlamydia. In 2001, she returned to Scotland and joined the University of Dundee, as a senior research associate under Alan Fairlamb. Wyllie researched on drug mechanism of action in Leishmania.

In 2015, Wyllie established the Mode of Action Group, a research group under the Wellcome Centre for Anti-Infectives Research. The group conducts studies to discover new drugs for chemically validated drug targets. In 2019, Wyllie became a principal investigator.

In 2024, she was appointed the professor of biochemical pharmacology. In 2026, Wyllie was elected a Fellow of the Royal Society of Edinburgh, in the discipline of biomedical and cognitive sciences.

Research

Wyllie's research is on kinetoplastid biology and parasitology. In February 2012, Wyllie was part of a team that identified fexinidazole as a treatment for Leishmaniasis. In recognition of her research, she was awarded the C. A. Wright Memorial Medal by the British Society for Parasitology.

To date, Wyllie has authored or co-authored more than 100 publications, and her research group has contributed to the development of five clinical drug candidates.

Personal life

Wyllie enjoys running, especially in Tentsmuir Forest.

Selected publications

References

  1. 1 2 3 4 "Getting to Know - Susan Wyllie". Wellcome Centre for Anti-Infectives Research, University of Dundee. 27 August 2020. Retrieved 26 October 2026.
  2. ↑ Wyllie, Susan (1998). Structural and functional characterisation of the major outer membrane protein of Chlamydia Psittaci (PhD thesis). University of Edinburgh. hdl:1842/22762. Retrieved 26 October 2026.
  3. ↑ "Leading academics awarded top honour". The Courier. 10 April 2026. Factiva COURIR0020260410em4a0001s.
  4. 1 2 "Professor Susan Wyllie". Royal Society of Edinburgh. Retrieved 26 October 2026.
  5. ↑ "Mode of Action Group". Mode of Action Group. 5 April 2019. Retrieved 26 October 2026.
  6. ↑ "Dr Susan Wyllie becomes Principal Investigator". University of Dundee. 25 July 2019. Retrieved 26 October 2026.
  7. 1 2 "Susan Wyllie awarded C.A. Wright Memorial Medal". University of Dundee. 17 April 2023. Retrieved 26 October 2026.
  8. 1 2 "Dundee academics elected Fellows of the RSE". University of Dundee. Retrieved 26 October 2026.
  9. 1 2 "People". Mode of Action Group. 25 February 2019. Retrieved 26 October 2026.
  10. ↑ "Professor Susan Wyllie". University of Dundee. Retrieved 26 October 2026.
  11. ↑ Wyllie, Susan; Patterson, Stephen; Stojanovski, Laste; Simeons, Frederick R. C.; Norval, Suzanne; Kime, Robert; Read, Kevin D.; Fairlamb, Alan H. (1 February 2012). "The Anti-Trypanosome Drug Fexinidazole Shows Potential for Treating Visceral Leishmaniasis". Science Translational Medicine. 4 (119): 119re1. doi:10.1126/scitranslmed.3003326. eISSN 1946-6242. ISSN 1946-6234. PMC 3457684. PMID 22301556.
  12. ↑ "Visceral Leishmaniasis; Potential new treatment identified for leishmaniasis". VerticalNews. Factiva JOUIND0020120217e82l00021.
  13. ↑ "Susan Wyllie". University of Dundee. Retrieved 26 October 2026.